Caplin Point Tamil Nadu unit passes FDA inspection with zero 483 observations

Share it

The unannounced inspection was conducted between August 5-9, 2024, Shares of Caplin Point Laboratories Ltd ended at ₹2,521.05, down by ₹15.45, or 0.61%, on the BSE.

Leave a Comment

Your email address will not be published. Required fields are marked *